Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Perlmutter

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Acta Crystallographica. Section F, Structural Biology Communications|March 19, 2014
Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonistNigus D Ambaye, Menachem J Gunzburg, Daouda A K Traore, et al.
Nanotechnology|February 25, 2016
Self-assembled nanomaterials based on beta (β(3)) tetrapeptidesRania S Seoudi, Mark G Hinds, David J D Wilson, et al.
Analytical Chemistry|May 11, 2013
The observation of dianions generated by electrochemical reduction of trans-stilbenes in ionic liquids at room temperatureOmar Abdul-Rahim, Alexandr N Simonov, Thomas Rüther, et al.
Journal of Neuroimmunology|December 3, 2014
Single β³-amino acid substitutions to MOG peptides suppress the development of experimental autoimmune encephalomyelitisCourtney A McDonald, Natalie L Payne, Guizhi Sun, et al.
APL Bioengineering|May 10, 2019
β<sup>3</sup>-tripeptides act as sticky ends to self-assemble into a bioscaffoldMark P Del Borgo, Ketav Kulkarni, Mary A Tonta, et al.
Organic & Biomolecular Chemistry|January 19, 2012
Conformational stability studies of a stapled hexa-β3-peptide libraryRomila D Gopalan, Mark P Del Borgo, Ylva E Bergman, et al.
Clinical Science (London, England : 1979)|July 18, 2015
β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive ratsMark Del Borgo, Yan Wang, Sanja Bosnyak, et al.
Scientific Reports|June 4, 2016
Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7Menachem J Gunzburg, Ketav Kulkarni, Gabrielle M Watson, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2011
A single beta-amino acid substitution to angiotensin II confers AT2 receptor selectivity and vascular functionEmma S Jones, Mark P Del Borgo, Julian F Kirsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivoAndrew I Webb, Michelle A Dunstone, Nicholas A Williamson, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Acta Crystallographica. Section F, Structural Biology Communications|March 19, 2014
Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonistNigus D Ambaye, Menachem J Gunzburg, Daouda A K Traore, et al.
Nanotechnology|February 25, 2016
Self-assembled nanomaterials based on beta (β(3)) tetrapeptidesRania S Seoudi, Mark G Hinds, David J D Wilson, et al.
Analytical Chemistry|May 11, 2013
The observation of dianions generated by electrochemical reduction of trans-stilbenes in ionic liquids at room temperatureOmar Abdul-Rahim, Alexandr N Simonov, Thomas Rüther, et al.
Journal of Neuroimmunology|December 3, 2014
Single β³-amino acid substitutions to MOG peptides suppress the development of experimental autoimmune encephalomyelitisCourtney A McDonald, Natalie L Payne, Guizhi Sun, et al.
APL Bioengineering|May 10, 2019
β<sup>3</sup>-tripeptides act as sticky ends to self-assemble into a bioscaffoldMark P Del Borgo, Ketav Kulkarni, Mary A Tonta, et al.
Organic & Biomolecular Chemistry|January 19, 2012
Conformational stability studies of a stapled hexa-β3-peptide libraryRomila D Gopalan, Mark P Del Borgo, Ylva E Bergman, et al.
Clinical Science (London, England : 1979)|July 18, 2015
β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive ratsMark Del Borgo, Yan Wang, Sanja Bosnyak, et al.
Scientific Reports|June 4, 2016
Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7Menachem J Gunzburg, Ketav Kulkarni, Gabrielle M Watson, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2011
A single beta-amino acid substitution to angiotensin II confers AT2 receptor selectivity and vascular functionEmma S Jones, Mark P Del Borgo, Julian F Kirsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivoAndrew I Webb, Michelle A Dunstone, Nicholas A Williamson, et al.
Pageof 5